Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
11/2005
11/17/2005CA2565667A1 Directly compressible tricalcium phosphate
11/17/2005CA2565269A1 Anti-microbial carrier systems
11/17/2005CA2564164A1 Biocompatible bone implant compositions and methods for repairing a bone defect
11/16/2005EP1595537A1 Buccal cavity treatment composition and corresponding uses thereof
11/16/2005EP1487472A4 Stabilization of hypoxia inducible factor (hif) alpha
11/16/2005EP1463823A4 Methods of increasing endogenous erythropoietin (epo)
11/16/2005EP1350516B1 Use of compositions for preventing or ameliorating multiple risk factor syndrome
11/16/2005EP1331919A4 Dental composition for hypersensitive teeth
11/16/2005EP1154953B1 Peroxochloric acid, derivatives and anions, salts thereof, method for producing them and use of the same
11/16/2005EP1107767B1 Use of selenium for treating systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
11/16/2005CN1697663A Antitumor agent and process for producing the same
11/16/2005CN1697662A Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
11/16/2005CN1695636A Application of fuller alcohol as ramification of C60 in nourishing hair
11/16/2005CN1695635A Oral compound preparation for treating skin disease
11/16/2005CN1695634A Combination of medication and health products for preventing and treating osteoporosis and osteoarthritis, and preparation method
11/16/2005CN1227014C Process for producing medicine or health-care food from abalone shells
11/15/2005US6964782 Stable hydrogen peroxide compositions, products and methods of use
11/15/2005CA2343148C Quick release pharmaceutical compositions of drug substances
11/10/2005WO2005105170A1 Bone substitute compositions and method of use
11/10/2005WO2005105120A2 Pharmaceutical combination, active on central nervous system (cns) and set of pharmaceuticals; method of treatment of cns-disorders; means facilitating penetration of the hematoencephalic barrier; pharmaceutical means for endonasal administration
11/10/2005WO2005105119A1 5-aminosalicylic acid of slow-released type in magnetic intercalated structure and the preparation method thereof
11/10/2005WO2005105118A1 Method for treating hypocalcemias, osteoporosis and fractures
11/10/2005WO2005105117A1 Trace elements
11/10/2005WO2005105116A2 Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
11/10/2005WO2005105098A2 Preparation for the treatment of cancer
11/10/2005WO2005105068A1 In vivo stimulation of intestinal transporters for excretion of nitrogenous wastes
11/10/2005WO2005104851A2 Insecticidal dispersion containing hydrophobic silica
11/10/2005WO2005104696A2 Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions
11/10/2005WO2005077385A3 Methods for treating resistant or refractory tumors
11/10/2005WO2005042142A3 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis
11/10/2005WO2005041924A3 Administration of levodopa and carbidopa
11/10/2005WO2004080417A3 Methods and compositions for blocking the calcium cascade
11/10/2005US20050251266 Biocompatible bone implant compositions and methods for repairing a bone defect
11/10/2005US20050251149 Bone substitute compositions and method of use
11/10/2005US20050250757 Use of targeted oxidative therapeutic formulation in treatment of cancer
11/10/2005US20050249825 Forming aqueous alkali or alkaline earth metal sulfamate solution; adding bromine chloride or elemental bromine; liquid has an active ingredient concentration of greater than 18% as Br or 8% as Cl, and a mole ratio of hydroxide ion to hydrogen ion source of 2.0:1 to 2.86:1; 1a or 2a bromosulfamate
11/10/2005US20050249823 Methods for the prevention or amelioration of neuropsychiatric and related diseases
11/10/2005US20050249822 Administration of cisplatin by inhalation
11/10/2005US20050249821 Nutritional supplement for treatment of ocular diseases
11/10/2005US20050249820 Nutritional supplement for the treatment and prevention of macular degeneration
11/10/2005US20050249819 Anti-microbial carrier systems
11/10/2005US20050249818 Polycationic antimicrobial therapeutic
11/10/2005US20050249817 Magnetic particle composition for therapeutic hyperthermia
11/10/2005US20050249813 Directly compressible tricalcium phosphate
11/10/2005US20050249773 Biocompatible bone implant compositions and methods for repairing a bone defect
11/10/2005US20050249770 Compositions and methods for treating or preventing inflammatory diseases
11/10/2005US20050249760 Human body affinitive lubricating protective and repair gel
11/10/2005US20050249727 Prevention and treatment of amyloidogenic disease
11/10/2005US20050249725 Improving cognitive function of individuals with beta amyloid disfunction utilizing beta amyloid specific immunoglobulin; immunotherapeutics
11/10/2005US20050247643 Treating impure water by introducing a solution of electrolyticially generated silver citrate into the impure water wherein the silver is electrolytically generated in a solution of citric acid and water
11/10/2005US20050247628 Devices for removing phosphate from biological fluids
11/10/2005CA2565832A1 Preparation for the treatment cancer
11/10/2005CA2564687A1 Bone substitute compositions and method of use
11/10/2005CA2556813A1 Trace elements
11/10/2005CA2553721A1 Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
11/09/2005EP1593381A1 Zinc oxide based formulation for preventing and treating diarrhea in farm animals
11/09/2005EP1592447A1 Devices and compositions containing boron and silicon for use in neutron capture therapy
11/09/2005EP1592427A1 Multivitamin regimen for renal patients
11/09/2005EP1096918B1 Skin and tissue care and/or treatment agent
11/09/2005EP1029456B1 Foods for preventing vomiting
11/09/2005EP0971745B1 Gel delivery vehicles for anticellular proliferative agents
11/09/2005CN1694690A Combination chemotherapy compositions and methods
11/08/2005US6962712 Cosmetic or dermatological composition comprising of a combination of an elastase inhibitor of the N-acylaminoamide family and at least one antifungal agent or at least one antibacterial agent
11/08/2005CA2123691C Antiviral compositions and method for their use
11/03/2005WO2005102929A1 Kaolinite-type laminated nanomaterial with structural fe3+, production method thereof and use of same
11/03/2005WO2005102925A1 Method of removing residual solvent from fullerene
11/03/2005WO2005102367A2 Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer
11/03/2005WO2005102366A2 Lithium combinations, and uses related thereto
11/03/2005WO2005102364A1 Compressed pharmaceutical compositions comprising peg and electrolytes
11/03/2005WO2005102295A1 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
11/03/2005WO2005102281A2 Porous calcium phosphate networks for synthetic bone material
11/03/2005WO2004108070A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers
11/03/2005US20050245618 Polyvinyl alcohol, borate, polysorbate, and benzalkonium chloride preservative, buffer, water; nonprescription
11/03/2005US20050245484 Lubricious germicidal ophthalmic solutions
11/03/2005US20050245468 Anthelmintic composition
11/03/2005US20050245467 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
11/03/2005US20050244513 Dispersion having an insecticidal action
11/03/2005US20050244512 Ophthalmic fluid and method of delivering same
11/03/2005US20050244511 Adding an EDTA/NaOH mixture to acontainer and subsequently adding at least one metal compound; adding Na2SeO3 to the container to obtain the trace element solution; improve the trace mineral status of an animal
11/03/2005US20050244510 Compositions for improving mental performance
11/03/2005US20050244509 Ophthalmic solutions
11/03/2005US20050244508 Anti-spasmodic comprising xenon
11/03/2005US20050244492 Rapidly disintegrating tablets comprising titanium dioxide
11/03/2005US20050244449 Silicon substituted oxyapatite
11/03/2005US20050244350 Composition including a pigment assembly comprising a mica core
11/03/2005US20050244344 Compositions for oral hygiene and method for using same
11/03/2005CA2835840A1 Beneficial effects of increasing local blood flow
11/03/2005CA2567249A1 Lithium combinations, and uses related thereto
11/03/2005CA2563749A1 Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer
11/03/2005CA2561553A1 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
11/02/2005EP1591143A1 Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
11/02/2005EP1590046A2 Composition for the treatment of hiv or aids
11/02/2005EP1589980A2 Methods of diagnosis and treatment of interstitial lung disease
11/02/2005EP1589961A2 A therapeutic composition for the treatment of hiv-1 and hiv-2
11/02/2005EP1589946A2 Solution for nostril wash
11/02/2005EP1589941A1 Composition for preventive treatment of cold sores
11/02/2005EP1368056B1 Recombinant gelatin-like proteins for use as plasma expanders
11/02/2005EP1272232B1 Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
11/02/2005EP1102767B1 Substituted pyrazole derivatives
11/02/2005CN1691949A Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases
1 ... 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 ... 563